PF 477736

CAT:
804-HY-10032-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
PF 477736 - image 1

PF 477736

  • Description:

    PF 477736 (PF 00477736) is a potent, selective and ATP-competitive inhibitor of Chk1, with a Ki of 0.49 nM, it is also a Chk2 inhibitor, with a Ki of 47 nM. PF 477736 shows VEGFR2, Fms, Yes, Aurora-A, FGFR3, Flt3, and Ret (IC50=8 (Ki), 10, 14, 23, 23, 25, and 39 nM, respectively) . PF 477736 can enhance Gemcitabine antitumor activity in vitro and in vivo[1][2].
  • Product Name Alternative:

    PF 00477736
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302, H315, H319, H335
  • Target:

    Aurora Kinase; CDK; c-Fms; Checkpoint Kinase (Chk) ; FGFR; FLT3; RET; Src; VEGFR
  • Type:

    Reference compound
  • Related Pathways:

    Cell Cycle/DNA Damage; Epigenetics; Protein Tyrosine Kinase/RTK
  • Applications:

    Cancer-Kinase/protease
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/PF-477736.html
  • Purity:

    99.04
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
  • Smiles:

    O=C([C@@H](C1CCCCC1)N)NC2=CC3=C(C(C=NNC4=O)=C(N3)C5=CN(N=C5)C)C4=C2
  • Molecular Formula:

    C22H25N7O2
  • Molecular Weight:

    419.48
  • Precautions:

    H302, H315, H319, H335
  • References & Citations:

    [1]Blasina A, et al. Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1. Mol Cancer Ther. 2008 Aug;7 (8) :2394-404|[2]Ashwell S, et, al. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy. Clin Cancer Res. 2008 Jul 1; 14 (13) : 4032-7.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Phase 1
  • Isoform:

    Aurora A; CDK1; Chk1; Chk2; VEGFR2/KDR/Flk-1
  • Citation 01:

    Cancers. 2019 Oct 25;11 (11) :1654.|Harvard Medical School LINCS LIBRARY|Research Square Preprint. 2022 Jul.|Sci Transl Med. 2018 Jul 18;10 (450) :eaaq1093.|Science. 2017 Dec 1;358 (6367) :eaan4368.|Exp Mol Med. 2021 Sep;53 (9) :1390-1401.
  • CAS Number:

    [952021-60-2]